These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A randomized trial shows dose-frequency and genotype may determine the therapeutic efficacy of intranasal oxytocin. Kou J; Zhang Y; Zhou F; Sindermann C; Montag C; Becker B; Kendrick KM Psychol Med; 2022 Jul; 52(10):1959-1968. PubMed ID: 33272333 [TBL] [Abstract][Full Text] [Related]
5. Effects of oxytocin and vasopressin on the neural response to unreciprocated cooperation within brain regions involved in stress and anxiety in men and women. Chen X; Hackett PD; DeMarco AC; Feng C; Stair S; Haroon E; Ditzen B; Pagnoni G; Rilling JK Brain Imaging Behav; 2016 Jun; 10(2):581-93. PubMed ID: 26040978 [TBL] [Abstract][Full Text] [Related]
6. Oxytocin increases amygdala reactivity to threatening scenes in females. Lischke A; Gamer M; Berger C; Grossmann A; Hauenstein K; Heinrichs M; Herpertz SC; Domes G Psychoneuroendocrinology; 2012 Sep; 37(9):1431-8. PubMed ID: 22365820 [TBL] [Abstract][Full Text] [Related]
7. Sex differences in the neural and behavioral response to intranasal oxytocin and vasopressin during human social interaction. Rilling JK; DeMarco AC; Hackett PD; Chen X; Gautam P; Stair S; Haroon E; Thompson R; Ditzen B; Patel R; Pagnoni G Psychoneuroendocrinology; 2014 Jan; 39():237-248. PubMed ID: 24157401 [TBL] [Abstract][Full Text] [Related]
8. Can repeated intranasal oxytocin administration affect reduced neural sensitivity towards expressive faces in autism? A randomized controlled trial. Moerkerke M; Daniels N; Van der Donck S; Tibermont L; Tang T; Debbaut E; Bamps A; Prinsen J; Steyaert J; Alaerts K; Boets B J Child Psychol Psychiatry; 2023 Nov; 64(11):1583-1595. PubMed ID: 37278339 [TBL] [Abstract][Full Text] [Related]
9. Intranasal Oxytocin Normalizes Amygdala Functional Connectivity in Posttraumatic Stress Disorder. Koch SB; van Zuiden M; Nawijn L; Frijling JL; Veltman DJ; Olff M Neuropsychopharmacology; 2016 Jul; 41(8):2041-51. PubMed ID: 26741286 [TBL] [Abstract][Full Text] [Related]
10. Oxytocin and social learning in socially anxious men and women. Flechsenhar A; Levine SM; Müller LE; Herpertz SC; Bertsch K Neuropharmacology; 2024 Jun; 251():109930. PubMed ID: 38537867 [TBL] [Abstract][Full Text] [Related]
11. Adult attachment style moderates the effect of oxytocin on neural responses to infant emotional faces. Ma Y; Liu G; Hu Y; Long W Int J Psychophysiol; 2022 Jan; 171():38-47. PubMed ID: 34919983 [TBL] [Abstract][Full Text] [Related]
12. Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome. Hall SS; Lightbody AA; McCarthy BE; Parker KJ; Reiss AL Psychoneuroendocrinology; 2012 Apr; 37(4):509-18. PubMed ID: 21862226 [TBL] [Abstract][Full Text] [Related]
13. Oxytocin reduces amygdala responses during threat approach. Radke S; Volman I; Kokal I; Roelofs K; de Bruijn ERA; Toni I Psychoneuroendocrinology; 2017 May; 79():160-166. PubMed ID: 28285187 [TBL] [Abstract][Full Text] [Related]
14. Oxytocin effects on amygdala reactivity to angry faces in males and females with antisocial personality disorder. Jeung-Maarse H; Schmitgen MM; Schmitt R; Bertsch K; Herpertz SC Neuropsychopharmacology; 2023 May; 48(6):946-953. PubMed ID: 36941365 [TBL] [Abstract][Full Text] [Related]
15. Effects of single- and multiple-dose oxytocin treatment on amygdala low-frequency BOLD fluctuations and BOLD spectral dynamics in autism. Alaerts K; Bernaerts S; Wenderoth N Transl Psychiatry; 2022 Sep; 12(1):393. PubMed ID: 36127337 [TBL] [Abstract][Full Text] [Related]
16. Oxytocin impacts top-down and bottom-up social perception in adolescents with ASD: a MEG study of neural connectivity. Korisky A; Gordon I; Goldstein A Mol Autism; 2022 Sep; 13(1):36. PubMed ID: 36064612 [TBL] [Abstract][Full Text] [Related]
17. Oxytocin induces long-lasting adaptations within amygdala circuitry in autism: a treatment-mechanism study with randomized placebo-controlled design. Alaerts K; Bernaerts S; Prinsen J; Dillen C; Steyaert J; Wenderoth N Neuropsychopharmacology; 2020 Jun; 45(7):1141-1149. PubMed ID: 32161366 [TBL] [Abstract][Full Text] [Related]
18. A phase II randomised controlled trial of intranasal oxytocin in anorexia nervosa. Maguire S; Kesby A; Brownlow R; Hunt GE; Kim M; McAulay C; Grisham JR; McGregor IS; Suraev A; Kevin RC; Russell J Psychoneuroendocrinology; 2024 Jun; 164():107032. PubMed ID: 38520886 [TBL] [Abstract][Full Text] [Related]
19. Oxytocinergic Modulation of Threat-Specific Amygdala Sensitization in Humans Is Critically Mediated by Serotonergic Mechanisms. Liu C; Lan C; Li K; Zhou F; Yao S; Xu L; Yang N; Zhou X; Yang J; Yong X; Ma Y; Scheele D; Kendrick KM; Becker B Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Nov; 6(11):1081-1089. PubMed ID: 33894423 [TBL] [Abstract][Full Text] [Related]
20. Oxytocin treatment attenuates amygdala activity in autism: a treatment-mechanism study with long-term follow-up. Bernaerts S; Boets B; Steyaert J; Wenderoth N; Alaerts K Transl Psychiatry; 2020 Nov; 10(1):383. PubMed ID: 33159033 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]